Scientific programme for ESPHI[removed]–6 October 2013 Friday, 4 October[removed]ID7

First Page		Document Content
Date: 2013-10-01 05:07:56 Coagulation system Deep vein thrombosis Thrombophilia Low molecular weight heparin Coagulation Rivaroxaban Anticoagulant Thrombosis Factor VII Blood Hematology Medicine		Scientific programme for ESPHI[removed]–6 October 2013 Friday, 4 October[removed]ID7 Add to Reading List Source URL: www.esphi.eu Download Document from Source Website File Size: 553,32 KB Share Document on Facebook

	NEWS The animal biotech sector reached a landmark in February when the US Food and Drug Administration (FDA) announced the approval of ATryn, an anticoagulant protein derived from the milk of transgenic goats. DocID: 1uEZf - View Document
	Anticoagulant Self-Management Plan      DocID: 1soRW - View Document
	American AmericanSociety Societyfor forClinical ClinicalLaboratory LaboratoryScience DocID: 1r26V - View Document
	5.5" MEDICATION GUIDE WARFARIN Warfarin Sodium Tablets, USP Crystalline Who should not take WARFARIN? DocID: 1qNvd - View Document
	American Society of Hematology Ten Things Physicians and Patients Should Question Don’t transfuse more than the minimum number of red blood cell (RBC) units necessary to relieve symptoms of anemia or to return a patie DocID: 1qEzi - View Document